EPA and DHA are fat-soluble omega-3 fatty acids that can be found in abundance in seafood, including fatty fish. They are also found in some grazed animal products. Although they are not the only source of EPA and DHA, they are essential for brain development. Research has indicated that EPA and DHA supplementation reduces the release of inflammatory factors, including IL-1B and granulocyte colony-stimulating factor. These findings indicate that EPA and DHA supplementation may be useful in preventing cognitive decline in people with mild to moderate Alzheimer's disease.

Market Dynamics:

Growing demand for concentrated form of omega-3 ingredients is predominantly fueling growth of the EPA and DHA market. Moreover, increasing demand for dietary supplements due to growing health awareness is again anticipated to foster market growth. Additionally, growing focus of key players to explore for extraction process for EPA is projected to provide significant growth opportunities over the forecast period. Furthermore, growing demand for vegan products and additives is gaining traction in the market.

On the Contrary, high market price is expected to hinder the market growth of EPA and DHA.

Key features of the study:

• This report provides in-depth analysis of the global EPA and DHA market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global EPA and DHA market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Koninklijke DSM NV, KD Pharma Group, The Archer Daniels Midland Company, Corbion NV, Novasep Holding SAS, Neptune Wellness Solutions, BASF SE, Clover Corporation Ltd, Croda International PLC, Novotech Nutraceuticals, and Polaris
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global EPA and DHA market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global EPA and DHA market

Detailed Segmentation:

• Global EPA and DHA Market, By Type:
  • Eicosapentaenoic Acid (EPA)
  • Docosahexaenoic Acid (DHA)
• Global EPA and DHA Market, By Source:
  • Fish Oil
  • Algae Oil
  • Krill Oil
  • Other Sources
• Global EPA and DHA Market, By Application:
  • Infant Formulae
  • Dietary Supplements
  • Fortified Food and Beverages
  • Pharmaceuticals
  • Other Applications
• Company Profiles
  • Koninklijke DSM NV*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • KD Pharma Group
  • The Archer Daniels Midland Company
  • Corbion NV
  • Novasep Holding SAS
  • Neptune Wellness Solutions
  • BASF SE
  • Clover Corporation Ltd
  • Croda International PLC
  • Novotech Nutraceuticals
  • Polaris

“*” marked represents similar segmentation in other categories in the respective section.